# TWFG, Inc.: financial statements, quarterly

TWFG · Nasdaq · CIK 2007596 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/twfg.md) · [Financials](/companies/twfg/financials.md) · [Filings](/companies/twfg/filings.md) · [Insiders](/companies/twfg/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/twfg/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [47.7](/filings/0002007596-24-000013.md) | [39.1 d](/filings/0001628280-26-016162.md) | [46.1](/filings/0001628280-25-025142.md) | [53.0](/filings/0002007596-25-000024.md) | [52.9](/filings/0001628280-25-051591.md) | [51.7 d](/filings/0001628280-26-016162.md) | [53.8](/filings/0001628280-26-032845.md) | [60.3](/filings/0002007596-26-000012.md) | [64.1](/filings/0001628280-25-051591.md) | [70.3 d](/filings/0001628280-26-016162.md) | [72.8](/filings/0001628280-26-032845.md) | [87.5](/filings/0002007596-26-000012.md) |
| Operating income | $m | [7.9](/filings/0002007596-24-000013.md) | [4.8 d](/filings/0001628280-26-016162.md) | [7.3](/filings/0001628280-25-025142.md) | [7.5](/filings/0002007596-25-000024.md) | [6.0](/filings/0001628280-25-051591.md) | [7.1 d](/filings/0001628280-26-016162.md) | [5.7](/filings/0001628280-26-032845.md) | [7.4](/filings/0002007596-26-000012.md) | [9.0](/filings/0001628280-25-051591.md) | [14.9 d](/filings/0001628280-26-016162.md) | [12.4](/filings/0001628280-26-032845.md) | [17.6](/filings/0002007596-26-000012.md) |
| Interest expense | $m | [0.3](/filings/0002007596-24-000013.md) | [0.5 d](/filings/0001628280-26-016162.md) | [0.8](/filings/0001628280-25-025142.md) | [0.9](/filings/0002007596-25-000024.md) | [0.4](/filings/0001628280-25-051591.md) | [0.1 d](/filings/0001628280-26-016162.md) | [0.1](/filings/0001628280-26-032845.md) | [0.1](/filings/0002007596-26-000012.md) | [0.1](/filings/0001628280-25-051591.md) | [0.1 d](/filings/0001628280-26-016162.md) | [0.1](/filings/0001628280-26-032845.md) | [0.1](/filings/0002007596-26-000012.md) |
| Income tax | $m | [0.0](/filings/0002007596-24-000013.md) | [0.0 d](/filings/0001628280-26-016162.md) | [0.0](/filings/0001628280-25-025142.md) | [0.0](/filings/0002007596-25-000024.md) | [0.4](/filings/0001628280-25-051591.md) | [1.1 d](/filings/0001628280-26-016162.md) | [0.7](/filings/0001628280-26-032845.md) | [0.6](/filings/0002007596-26-000012.md) | [1.0](/filings/0001628280-25-051591.md) | [1.0 d](/filings/0001628280-26-016162.md) | [1.1](/filings/0001628280-26-032845.md) | [1.0](/filings/0002007596-26-000012.md) |
| Net income | $m | [7.6](/filings/0002007596-24-000013.md) | [(20.9) d](/filings/0001628280-26-016162.md) | [0.0](/filings/0001628280-25-025142.md) | [0.0](/filings/0002007596-25-000024.md) | [1.2](/filings/0001628280-25-051591.md) | [8.2](/filings/0001628280-25-015138.md) | [1.3](/filings/0001628280-26-032845.md) | [2.0](/filings/0002007596-26-000012.md) | [1.7](/filings/0001628280-25-051591.md) | [36.1 d](/filings/0001628280-26-016162.md) | [1.8](/filings/0001628280-26-032845.md) | [2.4](/filings/0002007596-26-000012.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | [10.49](/filings/0002007596-24-000008.md) | [0.08](/filings/0001628280-25-051591.md) | not reported | [0.09](/filings/0001628280-26-032845.md) | [0.13](/filings/0002007596-26-000012.md) | [0.11](/filings/0001628280-25-051591.md) | not reported | [0.12](/filings/0001628280-26-032845.md) | [0.18](/filings/0002007596-26-000012.md) |
| Basic EPS | $ per share | not reported | not reported | not reported | [10.49](/filings/0002007596-24-000008.md) | [0.08](/filings/0001628280-25-051591.md) | not reported | [0.09](/filings/0001628280-26-032845.md) | [0.13](/filings/0002007596-26-000012.md) | [0.11](/filings/0001628280-25-051591.md) | not reported | [0.12](/filings/0001628280-26-032845.md) | [0.18](/filings/0002007596-26-000012.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-06-30) | period not labelled (2023-09-30) | period not labelled (2023-12-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [29.4](/filings/0002007596-24-000008.md) | [33.6](/filings/0002007596-24-000013.md) | [39.3](/filings/0001628280-26-016162.md) | [25.8](/filings/0002007596-24-000008.md) | [191](/filings/0002007596-24-000013.md) | [196](/filings/0001628280-26-016162.md) | [196](/filings/0001628280-26-032845.md) | [160](/filings/0002007596-25-000024.md) | [151](/filings/0001628280-25-051591.md) | [156](/filings/0002007596-26-000012.md) | [125](/filings/0001628280-26-032845.md) | [73.7](/filings/0002007596-26-000012.md) |
| Current assets | $m | not reported | not reported | [75.1](/filings/0001628280-25-015138.md) | [75.4](/filings/0002007596-24-000008.md) | [234](/filings/0002007596-24-000013.md) | [242](/filings/0001628280-26-016162.md) | [241](/filings/0001628280-25-025142.md) | [209](/filings/0002007596-25-000024.md) | [211](/filings/0001628280-25-051591.md) | [226](/filings/0002007596-26-000012.md) | [201](/filings/0001628280-26-032845.md) | [171](/filings/0002007596-26-000012.md) |
| Total assets | $m | not reported | not reported | [115](/filings/0001628280-25-015138.md) | [157](/filings/0002007596-24-000008.md) | [313](/filings/0002007596-24-000013.md) | [323](/filings/0001628280-26-016162.md) | [331](/filings/0001628280-25-025142.md) | [343](/filings/0002007596-25-000024.md) | [349](/filings/0001628280-25-051591.md) | [372](/filings/0002007596-26-000012.md) | [371](/filings/0001628280-26-032845.md) | [358](/filings/0002007596-26-000012.md) |
| Current liabilities | $m | not reported | not reported | [34.9](/filings/0001628280-25-015138.md) | [41.0](/filings/0002007596-24-000008.md) | [38.1](/filings/0002007596-24-000013.md) | [39.6](/filings/0001628280-26-016162.md) | [42.9](/filings/0001628280-25-025142.md) | [45.4](/filings/0002007596-25-000024.md) | [45.1](/filings/0001628280-25-051591.md) | [44.1](/filings/0002007596-26-000012.md) | [58.9](/filings/0001628280-26-032845.md) | [66.6](/filings/0002007596-26-000012.md) |
| Total liabilities | $m | not reported | not reported | [84.4](/filings/0001628280-25-015138.md) | [89.7](/filings/0002007596-24-000008.md) | [45.0](/filings/0002007596-24-000013.md) | [48.1](/filings/0001628280-26-016162.md) | [50.5](/filings/0001628280-25-025142.md) | [53.9](/filings/0002007596-25-000024.md) | [53.4](/filings/0001628280-25-051591.md) | [55.7](/filings/0002007596-26-000012.md) | [64.7](/filings/0001628280-26-032845.md) | [71.3](/filings/0002007596-26-000012.md) |
| Long-term debt | $m | not reported | not reported | [48.0](/filings/0001628280-25-015138.md) | [47.0](/filings/0002007596-24-000008.md) | [5.4](/filings/0002007596-24-000013.md) | [4.0](/filings/0001628280-26-016162.md) | [4.5](/filings/0001628280-25-025142.md) | [3.9](/filings/0002007596-25-000024.md) | [3.2](/filings/0001628280-25-051591.md) | [2.0](/filings/0002007596-26-000012.md) | [1.5](/filings/0001628280-26-032845.md) | [1.0](/filings/0002007596-26-000012.md) |
| Current portion of debt | $m | not reported | not reported | [2.8](/filings/0001628280-25-015138.md) | [2.6](/filings/0002007596-24-000008.md) | [2.4](/filings/0002007596-24-000013.md) | [1.9](/filings/0001628280-26-016162.md) | [2.5](/filings/0001628280-25-025142.md) | [2.5](/filings/0002007596-25-000024.md) | [2.6](/filings/0001628280-25-051591.md) | [2.0](/filings/0002007596-26-000012.md) | [2.0](/filings/0001628280-26-032845.md) | [2.0](/filings/0002007596-26-000012.md) |
| Short-term borrowings | $m | not reported | not reported | [2.4](/filings/0001628280-25-015138.md) | [2.0](/filings/0002007596-24-000008.md) | [1.9](/filings/0002007596-24-000013.md) | [1.9](/filings/0001628280-25-051591.md) | [1.9](/filings/0001628280-25-025142.md) | [1.9](/filings/0002007596-25-000024.md) | [2.0](/filings/0001628280-25-051591.md) | not reported | not reported | not reported |
| Shareholders' equity | $m | not reported | not reported | [31.1](/filings/0001628280-25-015138.md) | not reported | [71.1](/filings/0002007596-24-000013.md) | [73.9](/filings/0001628280-26-016162.md) | [75.2](/filings/0001628280-25-025142.md) | [78.7](/filings/0002007596-25-000024.md) | [79.4](/filings/0001628280-25-051591.md) | [83.4](/filings/0002007596-26-000012.md) | [69.2](/filings/0001628280-26-032845.md) | [46.2](/filings/0002007596-26-000012.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [7.4 d](/filings/0002007596-24-000013.md) | [6.1 d](/filings/0001628280-26-016162.md) | [9.8](/filings/0001628280-25-025142.md) | [7.4 d](/filings/0002007596-25-000024.md) | [11.7 d](/filings/0001628280-25-051591.md) | [11.6 d](/filings/0001628280-26-016162.md) | [15.6](/filings/0001628280-26-032845.md) | [9.6 d](/filings/0002007596-26-000012.md) | [15.0 d](/filings/0001628280-25-051591.md) | [13.3 d](/filings/0001628280-26-016162.md) | [22.7](/filings/0001628280-26-032845.md) | [9.8 d](/filings/0002007596-26-000012.md) |
| Capital expenditure | $m | [0.2 d](/filings/0002007596-24-000013.md) | [0.0 d](/filings/0001628280-26-016162.md) | [0.0](/filings/0001628280-25-025142.md) | [0.0 d](/filings/0002007596-25-000024.md) | [0.2 d](/filings/0001628280-25-051591.md) | [2.9 d](/filings/0001628280-26-016162.md) | [0.0](/filings/0001628280-26-032845.md) | [0.0 d](/filings/0002007596-26-000012.md) | [0.1 d](/filings/0001628280-25-051591.md) | [0.2 d](/filings/0001628280-26-016162.md) | [0.3](/filings/0001628280-26-032845.md) | [0.5 d](/filings/0002007596-26-000012.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001628280-26-032845.md) | [0.0 d](/filings/0002007596-26-000012.md) | not reported | not reported | [16.6](/filings/0001628280-26-032845.md) | [26.3 d](/filings/0002007596-26-000012.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | period not labelled (2023-06-30) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [0.6](/filings/0002007596-24-000008.md) | [0.7](/filings/0002007596-24-000008.md) | [14.9](/filings/0001628280-25-051591.md) | [15.1](/filings/0001628280-26-032845.md) | [56.3](/filings/0002007596-26-000012.md) | [15.1](/filings/0001628280-25-051591.md) | [14.9](/filings/0001628280-26-032845.md) | [13.1](/filings/0002007596-26-000012.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.